Lv6
1830 积分 2025-05-06 加入
前驱期阿尔茨海默病的简易筛查中国专家共识(2023年版)
21天前
已完结
3438 Neoadjuvant Radio-immunotherapy for Esophageal Squamous Cell Cancer: a phase II trial
1个月前
已完结
Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer
1个月前
已完结
Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 study
1个月前
已完结
Neoadjuvant Chemoimmunotherapy Combined With Node‐Sparing Radiotherapy for Clinical T3N+ Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Single‐Arm, Phase II Study (CINSREC Trial)
1个月前
已完结
Final overall survival analysis and exploratory biomarker study from JUPITER-06: a randomized phase III trial of toripalimab plus chemotherapy in advanced esophageal squamous-cell carcinoma
2个月前
已完结
Sintilimab plus concurrent chemoradiotherapy for treatment of locally advanced small cell lung cancer (SINCE-01): a phase II clinical trial
2个月前
已完结
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial
2个月前
已完结
Short-course-based TNT with or without PD-1 inhibitor for pMMR locally advanced rectal cancer: Phase 2 results of a randomized trial (STELLAR II)
2个月前
已完结
Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1
3个月前
已完结
皖公网安备34019202002308
